August 23, 2018
Rose
How to fit these therapies, that are innovative yet extremely expensive, into Medicare's payment model leaves advisers more confused than anything. In other pharmaceutical news, a curtain is pulled back on the drug development process and scientists look to create a new class of drugs to treat malaria.
from Kaiser Health News https://ift.tt/2LnphzT
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment